197 related articles for article (PubMed ID: 26414213)
1. Stereotactic body radiotherapy for head and neck cancer: an addition to the armamentarium against head and neck cancer.
Karam I; Poon I; Lee J; Liu S; Higgins K; Enepekides D; Sahgal A; Lo SS
Future Oncol; 2015; 11(21):2937-47. PubMed ID: 26414213
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
4. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
[TBL] [Abstract][Full Text] [Related]
5. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
Karam I; Yao M; Heron DE; Poon I; Koyfman SA; Yom SS; Siddiqui F; Lartigau E; Cengiz M; Yamazaki H; Hara W; Phan J; Vargo JA; Lee V; Foote RL; Harter KW; Lee NY; Sahgal A; Lo SS
Future Oncol; 2017 Mar; 13(7):603-613. PubMed ID: 27842456
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: When less is enough.
Swain M; Ghosh-Laskar S
Oral Oncol; 2021 May; 116():105265. PubMed ID: 33770592
[TBL] [Abstract][Full Text] [Related]
7. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration and tumor volume.
Vargo JA; Heron DE; Ferris RL; Rwigema JC; Kalash R; Wegner RE; Ohr J; Burton S
Head Neck; 2014 Sep; 36(9):1349-55. PubMed ID: 24038398
[TBL] [Abstract][Full Text] [Related]
8. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.
Strom T; Wishka C; Caudell JJ
Cancer Control; 2016 Jan; 23(1):6-11. PubMed ID: 27009451
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of stereotactic radiosurgery for head and neck malignancies.
Owen D; Iqbal F; Pollock BE; Link MJ; Stien K; Garces YI; Brown PD; Foote RL
Head Neck; 2015 Nov; 37(11):1557-62. PubMed ID: 24912475
[TBL] [Abstract][Full Text] [Related]
11. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer.
Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695
[TBL] [Abstract][Full Text] [Related]
12. [Stereotactic irradiation in head and neck cancers].
Benhaïm C; Lapeyre M; Thariat J
Cancer Radiother; 2014; 18(4):280-96. PubMed ID: 25059767
[TBL] [Abstract][Full Text] [Related]
13. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
[TBL] [Abstract][Full Text] [Related]
14. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
[TBL] [Abstract][Full Text] [Related]
15. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.
Lim CM; Clump DA; Heron DE; Ferris RL
Oral Oncol; 2013 May; 49(5):401-6. PubMed ID: 23332685
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.
Lee DS; Kim YS; Cheon JS; Song JH; Son SH; Jang JS; Kang YN; Kang JH; Jung SL; Yoo IeR; Jang HS
Radiat Oncol; 2012 Jun; 7():85. PubMed ID: 22691266
[TBL] [Abstract][Full Text] [Related]
18. Emerging applications of stereotactic radiotherapy in head and neck cancer.
Truong MT; Grillone G; Tschoe C; Chin L; Kachnic LA; Jalisi S
Neurosurg Focus; 2009 Dec; 27(6):E11. PubMed ID: 19951054
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
Ling DC; Vargo JA; Heron DE
Cancer J; 2016; 22(4):302-6. PubMed ID: 27441751
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck.
Vargo JA; Wegner RE; Heron DE; Ferris RL; Rwigema JC; Quinn A; Gigliotti P; Ohr J; Kubicek GJ; Burton S
Head Neck; 2012 Aug; 34(8):1153-61. PubMed ID: 22076812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
